Drug Interactions between copanlisib and Vitamin D3
This report displays the potential drug interactions for the following 2 drugs:
- copanlisib
- Vitamin D3 (cholecalciferol)
Interactions between your drugs
No interactions were found between copanlisib and Vitamin D3. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
copanlisib
A total of 322 drugs are known to interact with copanlisib.
- Copanlisib is in the drug class PI3K inhibitors.
- Copanlisib is used to treat Follicular Lymphoma.
Vitamin D3
A total of 72 drugs are known to interact with Vitamin D3.
- Vitamin d3 is in the drug class vitamins.
- Vitamin d3 is used to treat the following conditions:
Drug and food interactions
copanlisib food
Applies to: copanlisib
Grapefruit juice can increase the blood levels of copanlisib. This may increase side effects such as nausea, vomiting, diarrhea, mouth sores, high blood sugar, high blood pressure, lung or breathing problems, severe skin reactions, and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. You should avoid the consumption of grapefruit and grapefruit juice during treatment with copanlisib. Talk to your doctor or pharmacist if you have questions on this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.